Lewis Tanya

CIK 00014510383 companiesMINNEAPOLIS, MN

SEC Profile

Transactions

Companies

Filings

CIK

0001451038

Recent Transactions

26 trades

Award
DiaMedica Therapeutics Inc.$DMAC
Stock Option (right to buy)
2025-06-01+32,162→ 32,162 total
Award
DiaMedica Therapeutics Inc.$DMAC
Stock Option (right to buy)
2024-06-01+28,472→ 28,472 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2023-06-13$24.10/sh−12,043→ 136,110 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2023-06-13$23.45/sh−817→ 135,293 total
Award
DiaMedica Therapeutics Inc.$DMAC
Stock Option (right to buy)
2023-06-01+7,493→ 7,493 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2023-05-16$18.05/sh−12,207→ 148,153 total
Award
Replimune Group, Inc.$REPL
Common Stock
2023-04-01+40,000→ 160,360 total
Award
Replimune Group, Inc.$REPL
Employee Stock Option (right to buy)
2023-04-01+60,000→ 60,000 total
Award
DiaMedica Therapeutics Inc.$DMAC
Stock option (right to buy)
2023-03-01+26,443→ 26,443 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2022-05-16$14.59/sh−5,473→ 120,360 total
Award
Replimune Group, Inc.$REPL
Employee Stock Option (right to buy)
2022-04-01+78,750→ 78,750 total
Award
Replimune Group, Inc.$REPL
Common Stock
2022-04-01+52,500→ 125,833 total
Award
Replimune Group, Inc.$REPL
Employee Stock Option (right to buy)
2021-05-10+110,000→ 110,000 total
Award
Replimune Group, Inc.$REPL
Common Stock
2021-05-10+73,333→ 73,333 total
Award
Replimune Group, Inc.$REPL
Stock Option (right to buy)
2021-04-01+16,500→ 16,500 total
Award
Karyopharm Therapeutics Inc.$KPTI
Stock Option (right to buy)
2021-02-25+59,968→ 59,968 total
Award
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2021-02-25+22,013→ 45,401 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2021-02-11$15.52/sh−2,046→ 4,143 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2021-02-05+5,650→ 6,189 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Restricted Stock Units
2021-02-05−5,650→ 16,950 total
Award
Replimune Group, Inc.$REPL
Stock Option (right to buy)
2020-11-02+33,000→ 33,000 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-10-30$15.58/sh−226→ 539 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-10-28+765→ 765 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Restricted Stock Units
2020-10-28−765→ 2,295 total
Award
Karyopharm Therapeutics Inc.$KPTI
Stock Option (right to buy)
2020-02-05+60,600→ 60,600 total
Award
Karyopharm Therapeutics Inc.$KPTI
Restricted Stock Units
2020-02-05+22,600→ 22,600 total

Companies

Recent Filings

Address

301 CARLSON PARKWAY, SUITE 210

MINNEAPOLIS, MN, 55305

View on SEC.gov